Analysts Are Bullish on These Healthcare Stocks: Atricure (ATRC), Alkermes (ALKS)
TipRanksApr 29 19:18
AtriCure Analyst Ratings
BenzingaApr 23 19:39
Oppenheimer: The AtriCure (ATRC.US) rating was raised from Perform to be superior to the market rating. The target price was $32.00.
Zhitong FinanceApr 23 19:41
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
TipRanksApr 10 17:40
Needham: Reiterates AtriCure (ATRC.US) rating and adjusted from buy to buy rating, target price is $46.00.
Zhitong FinanceApr 10 17:40
AtriCure Analyst Ratings
BenzingaApr 10 17:31
Needham Reiterates Buy on AtriCure, Maintains $46 Price Target
BenzingaApr 10 17:34
UBS Adjusts AtriCure Price Target to $58 From $57, Maintains Buy Rating
MT NewswiresFeb 16 23:55
Oppenheimer Sticks to Its Hold Rating for Atricure (ATRC)
TipRanksFeb 16 20:57
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV)
TipRanksFeb 16 20:20
Atricure's Strong Performance and Growth Potential Merit a Buy Rating
TipRanksFeb 16 18:55
AtriCure Analyst Ratings
BenzingaFeb 16 18:40
UBS Adjusts AtriCure Price Target to $57 From $56, Maintains Buy Rating
MT NewswiresJan 23 00:38
AtriCure's Growth Trajectory: A Strong Buy Rating With Revenue Surge and Strategic Expansions
TipRanksJan 9 20:47
Atricure's Strong Growth and Positive Outlook Justify Buy Rating
TipRanksJan 9 02:25
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Ascendis Pharma (ASND) and G1 Therapeutics (GTHX)
TipRanksJan 8 23:10
Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Apollo Medical Holdings (AMEH) and Atricure (ATRC)
TipRanksJan 7 18:50
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and AbbVie (ABBV)
TipRanksJan 4 19:40
Needham Maintains Buy on AtriCure, Lowers Price Target to $44
BenzingaJan 4 19:27
AtriCure Analyst Ratings
BenzingaJan 4 19:26
No Data
No Data